MRK
$MRK
Merck & Co., Inc.
Global pharmaceutical leader known for Keytruda cancer immunotherapy and vaccines.
Healthcare$121.00
-0.57 (-0.47%)
Day Range$120.57 - $121.59
Prev Close$121.57
Analyst Rating
Strong Buy
21 Buy / 13 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Feb 22
Weekly updates
Latest Report
MRK: Merck Outlook — Pipeline, AI, and Risk-Adjusted Upside
Merck ($MRK) combines a high-margin oncology franchise, steady cash flow, and new AI partnerships to deepen its pipeline. Recent beats and strong analyst support make it a buy for long-term investors, while drug-specific and patent risks require active monitoring.
Feb 18, 2026